Skip to main content

Table 1 Demographic characteristics of the study cohort at baseline

From: Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study

Number of patients

230

Age, years (SD)

71.1 (9.2)

Men, n (%)

142 (61.7)

Women, n (%)

88 (38.3)

Diabetes duration, years (SD)

10.4 (2.5)

BMI, kg/m2 (SD)

26.4 (1.8)

Oral antidiabetic agents, n (%)

130 (56.5)

Insulin, n (%)

171 (74.3)

High blood pressure, n (%)

165 (71.7)

Hypercholesterolemia, n (%)

149 (149)

Smoking status

 Never smoked, n (%)

63 (27.4)

 Past smoker, n (%)

90 (39.1)

 Current smoker, n (%)

77 (33.5)

ABI (SD)

0.63 (0.2)

Rutherford staging

 Stage 4, n (%)

106 (46.1)

 Stage 5, n (%)

124 (53.9)

WIfI classification

 WIfI 010, n (%)

45 (19.6)

 WIfI 020, n (%)

53 (23.0)

 WIfI 110, n (%)

64 (27.8)

 WIfI 120, n (%)

68 (29.6)

Previous coronary artery disease, n (%)

105 (45.7)

Previous cerebrovascular disease, n (%)

124 (53.9)

Total cholesterol, mg/dL (SD)

191.8 (28.2)

LDL cholesterol, mg/dL (SD)

113.2 (20.6)

Triglycerides, mg/dL (SD)

181.1 (27.3)

Glucose, mg/dL (SD)

120.7 (12.9)

HbA1C, % (SD)

8.9 (2.0)

eGFR, mL/min/1.73 m2 (SD)

71.1 (12.8)

Sortilin, ng/mL (SD)

1.9 (0.6)

  1. Data are reported as means (standard deviation) for continuous variables and numbers (percentages) for categorical variables. BMI Body Mass Index, ABI Ankle Brachial Index, WIfI Wound, ischemia, foot infection, LDL low-density lipoprotein, eGFR estimated glomerular filtration rate